The majority of IDH-mutant astrocytomas possess methylated MGMT promoters, and compared to IDH-wildtype glioblastomas, IDH-mutant tumours show significantly higher MGMT promoter methylation. This evidence concerns the gene IDH2 and glioblastoma.